The prominent role of serotonergic degeneration in apathy, anxiety and depression inde novoParkinson’s disease

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

(2017) Philippe De Deurwaerdère et al.   PROGRESS IN NEUROBIOLOGY

Emotional manifestations of PD: Neurobiological basis

(2016) Anna Castrioto et al.   MOVEMENT DISORDERS

Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease

(2015) Zahi Qamhawi et al.   BRAIN

Interaction Between Brain Histamine and Serotonin, Norepinephrine, and Dopamine Systems: In Vivo Microdialysis and Electrophysiology Study

(2015) Gunnar Flik et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease

(2015) J. Joutsa et al.   JOURNAL OF NUCLEAR MEDICINE

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study

(2015) Anette Schrag et al.   LANCET NEUROLOGY

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

(2015) Javier Pagonabarraga et al.   LANCET NEUROLOGY

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

(2015) Daniel Weintraub et al.   MOVEMENT DISORDERS

Pharmacotherapy of neuropathic pain

(2015) Nadine Attal et al.   PAIN

Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients

(2015) Gabriella Santangelo et al.   PARKINSONISM & RELATED DISORDERS

New insight into the therapeutic role of the serotonergic system in Parkinson's disease

(2015) Yukihiro Ohno et al.   PROGRESS IN NEUROBIOLOGY

Clinical spectrum of impulse control disorders in Parkinson's disease

(2014) Daniel Weintraub et al.   MOVEMENT DISORDERS

Apathy in untreated early-stage Parkinson disease: Relationship with other non-motor symptoms

(2014) Kathy Dujardin et al.   MOVEMENT DISORDERS

Course of psychiatric symptoms and global cognition in early Parkinson disease

(2014) P. de la Riva et al.   NEUROLOGY

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil

(2013) Stéphane Thobois et al.   BRAIN

A volumetric MRI study of limbic, associative and sensorimotor striatal subregions in schizophrenia

(2013) James J. Levitt et al.   SCHIZOPHRENIA RESEARCH

Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression

(2012) Paul E. Holtzheimer   ARCHIVES OF GENERAL PSYCHIATRY

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

(2012) I. H. Richard et al.   NEUROLOGY

Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease

(2011) Benedicte Ballanger et al.   MOVEMENT DISORDERS

Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease

(2011) F.M. Skidmore et al.   NEUROIMAGE

Physical and clinical performance of the mCT time-of-flight PET/CT scanner

(2011) B W Jakoby et al.   PHYSICS IN MEDICINE AND BIOLOGY

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

(2010) S. Thobois et al.   BRAIN

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction

(2010) N. Pavese et al.   BRAIN

Midbrain serotonin transporters in de novo and L-DOPA-treated patients with early Parkinson’s disease - a [123I]-ADAM SPECT study

(2010) J. C. Beucke et al.   EUROPEAN JOURNAL OF NEUROLOGY

Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter

(2010) Karl Strecker et al.   JOURNAL OF NEUROLOGY

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2010) Paolo Barone et al.   LANCET NEUROLOGY

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

(2010) Marios Politis et al.   NEUROBIOLOGY OF DISEASE

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

(2010) M. Politis et al.   NEUROLOGY

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease

(2009) I. Boileau et al.   BRAIN

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

(2009) K Ray Chaudhuri et al.   LANCET NEUROLOGY

Neuropsychiatric symptoms in Parkinson's disease

(2009) Dag Aarsland et al.   MOVEMENT DISORDERS

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

(2009) Paolo Barone et al.   MOVEMENT DISORDERS

Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson

(2009) C. Ardouin et al.   REVUE NEUROLOGIQUE

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB

(2008) Isabelle Boileau et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest

(2007) Ioannis S. Gousias et al.   NEUROIMAGE